Yonhap Infomax NewsMay 22, 2025
Samsung Biologics announces spin-off to resolve CDMO-biosimilar conflicts, aiming to enhance growth potential and investor clarity in both business segments
#YonhapInfomax #SamsungBiologics #CDMO #Biosimilars #CorporateSpinoff #ConflictOfInterest #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64313
Samsung Biologics - 'Securing Growth Momentum by Resolving CDMO-Biosimilar Conflicts of Interest'

Samsung Biologics announces spin-off to resolve CDMO-biosimilar conflicts, aiming to enhance growth potential and investor clarity in both business segments

Yonhap Infomax
Yonhap Infomax NewsMay 22, 2025
Kakao spins off Content CIC to form 'Daum Preparation New Corporation', aiming for enhanced efficiency and business competitiveness in portal operations
#YonhapInfomax #Kakao #ContentCIC #DaumPortal #CorporateSpinoff #BusinessRestructuring #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64321
Kakao to Spin Off Content CIC, Establishes 'Daum Preparation New Corporation'

Kakao spins off Content CIC to form 'Daum Preparation New Corporation', aiming for enhanced efficiency and business competitiveness in portal operations

Yonhap Infomax
Yonhap Infomax NewsMay 22, 2025
Samsung Biologics clarifies that its recent spin-off decision is independent of any broader Samsung Group restructuring plans, addressing market speculation
#YonhapInfomax #SamsungBiologics #CorporateSpinOff #GroupRestructuring #MarketSpeculation #CorporateStatement #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64303
Samsung Biologics - 'This Spin-off Not Related to Group Restructuring'

Samsung Biologics clarifies that its recent spin-off decision is independent of any broader Samsung Group restructuring plans, addressing market speculation

Yonhap Infomax
Yonhap Infomax NewsMay 2, 2025
HS Hyosung reports Q1 2025 results with 454.53 billion won in sales and 9.567 billion won in operating profit, showcasing the newly established company's financial performance
#YonhapInfomax #HSHyosung #Q1Results #OperatingProfit #Sales #CorporateSpinOff #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=61570
HS Hyosung Posts Q1 Operating Profit of 9.56 Billion Won - Sales Reach 454.53 Billion Won

HS Hyosung reports Q1 2025 results with 454.53 billion won in sales and 9.567 billion won in operating profit, showcasing the newly established company's financial performance

Yonhap Infomax